IDNs and GPOs: Changing the Leopard's Spots
Ten years ago, hospital suppliers believed IDNs (integrated delivery networks) would challenge and eventually put GPOs out of business by introducing a new type of customer. Well, IDNs are certainly a force to be reckoned with. But GPOs have adapted by accommodating the new providers, and AmeriNet's Options program may be the best example of such an accommodation. In the process, GPOs are subtly changing their basic philosophy, jettisoning a one-size-fits-all approach for one that allows individual members to craft their own deals.
You may also be interested in...
Drug companies have their last chance to negotiate which documents and information Italy’s regulator, AIFA, will be entitled to request of them when they submit pricing and reimbursement applications.
Sandoz sees key opportunities ahead in both the US and Canadian biosimilars markets, the firm’s US vice-president for marketing, market access and patient services, Sheila Frame, tells Generics Bulletin in the second part of an exclusive interview.
As the final scheduled round of post-Brexit trade talks begins amid growing concern over the prospect of a deal and the pervasive threat of COVID-19, the pharmaceutical industry in the UK and the EU have issued an urgent call for an MRA on medicines GMP. They also want to see a one-year phase-in of medicines-related aspects of the Northern Ireland Protocol.